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Helicobacter acinonychis: Genetic and Rodent Infection Studies of a
Helicobacter pylori-Like Gastric Pathogen of Cheetahs and
Other Big Cats
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Kathryn A. Eaton,2‡ Giovanni Cattoli,3§ Johannes G. Kusters,4 and Douglas E. Berg1*
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School of Medicine, Vrije Universitet Medical Center, Amsterdam,3 and Department of Gastroenterology and
Hepatology, Erasmus MC—University Medical Center Rotterdam, Rotterdam,4 The Netherlands
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Insights into bacterium-host interactions and genome evolution can emerge from comparisons among
related species. Here we studied Helicobacter acinonychis (formerly H. acinonyx), a species closely related to the
human gastric pathogen Helicobacter pylori. Two groups of strains were identified by randomly amplified
polymorphic DNA fingerprinting and gene sequencing: one group from six cheetahs in a U.S. zoo and two lions
in a European circus, and the other group from a tiger and a lion-tiger hybrid in the same circus. PCR and
DNA sequencing showed that each strain lacked the cag pathogenicity island and contained a degenerate
vacuolating cytotoxin (vacA) gene. Analyses of nine other genes (glmM, recA, hp519, glr, cysS, ppa, flaB, flaA, and
atpA) revealed a 2% base substitution difference, on average, between the two H. acinonychis groups and a
8% difference between these genes and their homologs in H. pylori reference strains such as 26695. H.
acinonychis derivatives that could chronically infect mice were selected and were found to be capable of
persistent mixed infection with certain H. pylori strains. Several variants, due variously to recombination or
new mutation, were found after 2 months of mixed infection. H. acinonychis ’ modest genetic distance from H.
pylori, its ability to infect mice, and its ability to coexist and recombine with certain H. pylori strains in vivo
should be useful in studies of Helicobacter infection and virulence mechanisms and studies of genome evolution.
Functional and sequence comparisons among related bacte-
rial strains and species can provide insights into evolutionary
mechanisms and help identify factors that contribute to the
virulence of pathogens (37, 51). Here we report studies of
strains of Helicobacter acinonychis (formerly H. acinonyx),
which chronically infects the gastric mucosa of cheetahs and
other big cats and that, based on 16S rRNA sequence data,
seems to be the most closely related of known helicobacters to
the human gastric pathogen Helicobacter pylori (12, 13, 45).
Chronic infection of cheetahs by H. acinonyx is thought to
contribute to the development of severe gastritis, a frequent
cause of their death in captivity (12, 35).
H. pylori itself is a most genetically diverse species: indepen-
dent clinical isolates are usually distinguishable by DNA fin-
gerprinting (4) and typically differ from one another by some
2% or more in sequences of essential housekeeping genes and
5% or more in gene content (1, 3, 5, 43). This diversity prob-
ably stems from a combination of factors, including (i) muta-
tion (50); (ii) recombination between divergent strains and
species (1, 5, 16, 46, 47); (iii) selection for host-specific adap-
tation during chronic infection, which reflects differences be-
tween people and also within individual stomachs in traits that
can be important to H. pylori (2, 11, 25, 33); and (iv) a highly
localized (preferentially intrafamilial) pattern of transmission
(22, 38), which promotes genetic drift and minimizes the
chance of selection for just one or a few potentially most-fit
genotypes.
It is not known when H. pylori became human adapted. One
theory proposes that its association with humans is truly an-
cient, that H. pylori infection has been near universal in hu-
mans and in our nonhuman primate ancestors for perhaps
millions of years (6). This proposal was used in developing a
controversial idea that chronic H. pylori infection and the gas-
tritis accompanying it might be quite normal and, thus, it bears
on discussions of whether H. pylori eradication should or
should not be a societal goal (6). Our alternative theory (29)
proposes that H. pylori infection became widespread in humans
more recently, perhaps in early agricultural societies, some
10,000 years ago. As with the jumps of other pathogens in
humans, this might have been promoted by the increased con-
tact with animals, the higher population density, and the
poorer sanitation in agricultural communities than in bands of
hunter-gatherers (10, 29). The potential of H. pylori to sur-
mount barriers between host species is illustrated by the many
reports of human H. pylori strains adapted to mice and other
mammals (11, 18, 19, 31, 42). The present study of H. pylori’s
close relative, H. acinonychis, was motivated by interest in
* Corresponding author. Mailing address: Department of Molecular
Microbiology, Campus Box 8230, Washington University School of
Medicine, St. Louis, MO 63110. Phone: (314) 362-2772. Fax: (314)
362-1232. E-mail: berg@borcim.wustl.edu.
† Present address: National Institute of Cholera and Enteric Dis-
eases, Calcutta-700010, India.
‡ Present address: Unit for Laboratory Animal Medicine, University
of Michigan, Ann Arbor, MI 48109-0614.
§ Present address: Department of Veterinary Public Health and
Animal Pathology, Faculty of Veterinary Medicine, University of Bo-
logna, Bologna, Italy.
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understanding the control and specificity of infection, of how
and when H. pylori may have become widespread in humans,
and by the potential value of comparing related Helicobacter
species in this context.
Earlier studies had shown that H. acinonychis could infect
domestic cats (13), as can certain H. pylori strains (39), al-
though an attempt to infect BALB/c mice was not successful
(13). Part of a putative adhesin gene of H. acinonychis (hxaA)
was 83% matched to that of H. pylori (hpaA [14]), and point
mutations could be moved between H. pylori and H. aci-
nonychis by DNA transformation in culture (40). Here we
characterize sequence relationships of H. acinonychis isolates
from captive big cats from North America and Europe to each
other and to human H. pylori, identify two distinct groups of
strains, and select H. acinonychis derivatives that can chroni-
cally infect mice either alone or in combination with certain H.
pylori strains.
MATERIALS AND METHODS
Helicobacter strains and culture. Ten veterinary isolates of H. acinonychis were
studied here. Six, named 89-2579, 90-119, 90-548, 90-624, 90-736, and 90-788,
were from cheetahs with gastritis in the Columbus (Ohio) Zoo. HindIII digest
genomic DNA profiling had indicated that these isolates were closely related to
one another (12, 13). Four additional H. acinonychis strains were from animals
in a European Circus: two from lions (named Sheeba and Mac), one from a tiger
(named India), and one from a lion-tiger hybrid (named Sheena) (8, 40; G.
Cattoli and J. G. Kusters, unpublished data). Each of these big cats was born in
captivity. The six zoo animals may have been in contact with one another, directly
and/or via handlers, utensils, etc., as may have been the four circus animals. To
our knowledge, however, there had been no contact between the big cats in the
United States and those in Europe, and it is not known when their ancestors were
captured in the wild.
Five mouse-adapted strains of H. pylori were used here: SS1 (31, 36); X47 (also
known as X47-2AL [2, 15]); 88-3887, a close relative of strain 26695 (24, 27, 34),
whose genome has been fully sequenced (47); and AM1 from India and AL10103
from Alaska (D. Dailidiene, A. K. Mukhopadhyay, M. Zhang, and D. E. Berg,
unpublished data).
Helicobacter strains were grown in a gas-controlled incubator under mi-
croaerobic conditions (5% O2, 10% CO2, 85% N2) at 37°C, usually on brain
heart infusion agar (Difco) supplemented with 7% horse blood, 0.4% Iso-
VitaleX, and the antibiotics amphotericin B (8 g per ml), trimethoprim (5 g
per ml), and vancomycin (6 g per ml). Nalidixic acid (10 g per ml), polymixin
B (10 g per ml), and bacitracin (200 g per ml) were added to this medium
when culturing Helicobacter isolates from mouse stomachs. H. acinonychis iso-
lates were tested for susceptibility to metronidazole (MTZ) by spotting aliquots
of diluted cultures containing, variously, 103 to 106 cells (10-fold dilutions) on
media with fixed concentrations of antibiotics, as described elsewhere (9, 26).
Tests for susceptibility to other antibiotics (tetracycline [Tet], clarithromycin
[Cla], and chloramphenicol [Cam]) were carried out similarly but by spotting
only about 106 cells on drug-containing media.
Strains carrying rRNA resistance mutations were constructed by transforma-
tion with 16S ribosomal DNA (rDNA) containing TTC in place of AGA at
position 965 to 967 for Tet resistance (9) and 23S rDNA containing G in place
of A at position 2144 for Cla resistance (49). Strains carrying vacA::cat (K. Ogura
and D. E. Berg, unpublished data) and rdxA::cat (26) (chloramphenicol resis-
tance) mutations were similarly generated by transformation (26) as needed.
Mice. Mice of three inbred lines were used here: C57BL/6J wild type; the
congenic C57BL/6J interleukin-12 (IL-12; p40 large subunit) homozygous
mutant knockout line; and BALB/cJ (all from Jackson Laboratories [hence, “J”
designation], Bar Harbor, Maine). These mice were maintained in the Washing-
ton University Medical School Animal Quarters (Animal Welfare Assurance
A-3381-01) with water and standard mouse chow ad libitum and used in proto-
cols approved by the Washington University Animal Studies Committee (ap-
proval 20010039).
Experimental infection. Helicobacter cultures were grown overnight on brain
heart infusion agar and suspended in phosphate-buffered saline at densities of
approximately 2  109 CFU per ml. A 0.5-ml aliquot of this suspension was used
for each inoculation. In cases of mice inoculated with two strains, the 0.5-ml
suspension contained an equal amount of each strain (final concentration, 2 
109 CFU per ml). To score colonization, mice were sacrificed by CO2 asphyxi-
ation and cut open with clean sterile scissors immediately after; their stomachs
were removed and cut longitudinally along the lesser curvature, and any gastric
contents were removed with clean, sterile forceps. The forestomach (not a major
site of H. pylori colonization), which was identified as a rather thin structure that
is separated from the corpus by a white line, was removed and discarded. The
remainder of the stomach was homogenized, and the homogenate or dilutions of
it were spread on agar medium.
DNA methods. Helicobacter genomic DNAs were isolated from confluent cul-
tures grown on agar medium using a QIAamp DNA mini kit (Qiagen Corpora-
tion, Chatsworth, Calif.). Randomly amplified polymorphic DNA (RAPD) fin-
gerprint analysis was carried out essentially as described previously (4) in 25-l
reaction mixtures containing either 5 or 20 ng of genomic DNA (to assess
reproducibility of patterns), 5 mM MgCl2, 20 pmol of each of four arbitrary
primers (Table 1), a 0.25 mM concentration of each deoxynucleoside triphos-
phate, and 1 U of Biolase thermostable DNA polymerase (Midwest Scientific, St.
Louis, Mo.) in 10 mM Tris-HCl (pH 8.3), 50 mM KCl under the following cycling
conditions: 45 cycles of 94°C for 1 min, 36°C for 1 min, and 72°C for 2 min.
Gene-specific PCR was carried out in 20-l volumes containing 5 to 10 ng of
DNA, 0.25 to 0.5 U of Taq polymerase (Biolase; Midwest Scientific), 2.5 pmol of
each primer (Table 1), and a 0.25 mM concentration of each deoxynucleoside
triphosphate, in a standard buffer for 30 cycles with the following cycling param-
eters: denaturation at 94°C for 30 s, annealing generally at 52°C (low stringency,
to compensate for possible mismatches with H. acinonychis sequences) for 30 s,
and DNA synthesis at 72°C for an appropriate time (1 min per kb). PCR
products for sequencing were purified with a PCR purification kit (Qiagen) or
extracted from agarose by centrifugation with Ultrafree-DA (Amicon, Milli-
pore). DNA sequencing was carried out using a Big Dye Terminator DNA
sequencing kit (Perkin-Elmer) and ABI automated sequencers. Direct sequenc-
ing of PCR products was done with 5 l of PCR fragment (about 100 ng of
DNA), 1 l of primer (1.6 pM), and 4 l of Big Dye under the following
conditions: 25 cycles of denaturation at 96°C for 10 s, annealing at 50°C for 5 s,
and extension at 60°C for 4 min under oil-free conditions (Perkin-Elmer 2400).
DNA sequence editing, alignment, and analysis were performed with the Vector
NTI suite of programs (Informax, Bethesda, Md.) and with programs and data in
the H. pylori Genome Sequence Databases (5, 47) and Blast and pfam (version
5.3) homology search programs (http://www.ncbi.nlm.nih.gov/blast/blast.cgi;
http://pfam.wustl.edu/hmmsearch.shtml). Diversity within and between taxa were
analyzed using MEGA 2.1 (30). Phylogenetic analysis was performed using the
neighbor-joining approach as implemented in PAUP version 4b10 (D. Swofford,
Sinauer Associates). To determine the significance of observed groupings in the
phylogeny, bootstrap analysis (PHYLIP Phylogeny Inference Package, version
3.573c; J. Felsenstein, Department of Genetics, University of Washington, 1993)
was performed with 1,000 replicates in a neighbor-joining (41) environment, with
Jukes-Cantor two-parameter distances as implemented in PAUP version 4b10
or/and PHYLIP version 3.573c.
Nucleotide sequence accession numbers. The nucleotide sequences analyzed
in this study were deposited in the NCBI GenBank database under accession
numbers AY269142 to AY269185. The primers used for PCR and sequencing
are listed in Table 1.
RESULTS
Phylogenetic relationships. We studied H. acinonychis iso-
lates from six cheetahs from a zoo in Ohio and from two lions,
a tiger, and a lion-tiger hybrid from a European circus. Two H.
acinonychis groups were identified by RAPD fingerprinting
(Fig. 1). Group I contained all isolates from the cheetahs from
the Ohio zoo and also two lions from the European circus;
group II contained isolates from the tiger and the lion-tiger
hybrid from the same circus. Two variants were found among
group I isolates, differing reproducibly in 3 of 34 bands that
were generated with four RAPD primers (Fig. 1). The two
group II isolates also differed slightly but reproducibly from
one another (Fig. 1).
Lack of cag PAI. Two sets of PCR tests indicated that H.
acinonychis strains lack the cag pathogenicity island (PAI).
First, no amplification was obtained with DNAs from group I
VOL. 186, 2004 GENETICS OF H. ACINONYCHIS 357
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or group II strains with sets of primers specific for the cagA
gene nor for any of 11 other cag PAI genes (picA and picB, also
near the right end, and hp520, hp522, hp524, and hp526-hp531
at or near the left end [47]). Although the cagA gene is so
diverse in H. pylori populations that a lack of PCR amplifica-
tion might be considered inconclusive (48, 52), an equivalent
lack of amplification with all other cag PAI genes tested
seemed definitive. This reasoning is based primarily on the
TABLE 1. Primers for PCR and sequencing
Gene Primer name Sequence (5-3)a Length of PCRfragment (bp)
glmM (ureC) glmM F 5-TTTGGGACTGATGGCGTGAGGG 1,303
glmM R 5-TCTTTTAATTCTTGCATTTTGGATTCTA
recA recA1 F 5-GCGTTGGTACGCCTTGGGGATAAGCAA 833
recA4 R 5-GCCTTGCCCTAGCTTTTTATCCTGGT
hp519 519 F1 5-GGCTTTTTCATAGCCAAATTCTGCG 740
519 R1 5-GTTGCCGTTTTCRCTTTGTATAGCT
picB cagE-F 5-CACTCTCAATGAACCCGTTATG 700
cagE-R 5-GACGCATTCCTTAACGCTTTGT
picA cagD-F 5-CATAAGAATTGAATACGGCCAATA 1,000
cagAR-0429 5-TAGTGGTCTATGGAGTTG
glr 5733 5-CACATCGCCGCTCGCATGA 800
6544 5-AAGCTTTGTGTATTCTAAAATGCAAC
ppa ppa8 5-CCCCTAGAAAATCCTATTTTGATAATC 902
ppa9 5-AGTGGTGAGCTTTAGCGACGCTC
cysS cysS-F 5-CTACGGTGTATGATGACGCTCA 1,287
cysS-R 5-CCTTGTGGGGTGTCCATCAAAG
atpA atpA1 5-GCTTAAATGGTGTGATGTCG 1,200
atpA6 5-CTTATTCGCCCTTGCCCATT
vacA cysS-F2b 5-TGATGGACACCCCACAAGG 530
va1-R 5-CTGCTTGAATGCGCCAAAC
2579-F2b 5-AGGTGTCGCTTCAAGAACAGCCGG 1,580
2579-R2 5-GAGCATTTTCCCGCACTCATACCATG
2579-F3b 5-GTGTGGATGGGCCGTTTGCAATAT 1,000
2579-R2 5-GAGCATTTTCCCGCACTCATACCATG
Vam-Fb 5-GGCCCCAATGCAGTCAGTGAT 706
Vam-R 5-GCTGTTAGTGCCTAAAGAAGCAT
vac6-Fb 5-TAATAGAGCAATTCAAAGAGCGCC 790
vac6-R 5-CCAAAHCCDCCYACAATRGCTT
vac7-Fb 5-CCAATGTTTGGGCTAACGCTATTGG 950
vac7-R 5-GCRYGGKTTTAAGACCGGTATTT
vacAs va1-F 5-ATGGAAATACAACAAACACAC s1,259
va1-R 5-CTGCTTGAATGCGCCAAAC s2,286
vacAs vac5-Fc 5-GTGTCGCTTCAAGAACAGC 100
vac5-R 5-CCCAACCCTAATCTCYTTG
vacAmd vam-F 5-GGCCCCAATGCAGTCAGTGAT 706
vam-R 5-GCTGTTAGTGCCTAAAGAAGCAT
vacAm2e va4-F 5-GGAGCCCCAGGAAACATTG 352
va4-R 5-CATAACTAGCGCCTTGCAC
flaA flaA-F 5-AAGAATTYCAAGTDGGKGCTTATTYTAAC 870
flaA-R 5-TTTTTGCACAGAACCYAARTCAGAKCGSAC
flaB flaB-F 5-TTTWCTAAYAAAGAATTTCAAATYGGHGCG 675
flaB-R 5-CTGAARTTCACVCCGCTCACRATRATGTC
cag empty site luni1 5-ACATTTTGGCTAAATAAACGCTG 535
r5280 5-GGTTGCACGCATTTTCCCTTAATC
cag empty site luni 1 5-ACATTTTGGCTAAATAAACGCTG 850
P4 5-GCTTTGGATTTTTTCAAACCGCA
16s rDNA 16s-F 5-CGGTTACCTTGTTACGACTTCAC 1,400
16s-R 5-TATGGAGAGTTTGATCCTGGCTC
RAPD primers
1254 5-CCGCAGCCAA
1281 5-AACGCGCAAC
1283 5-GCGATCCCCA
1290 5-GTGGATGCGA
a For mixed bases, the following code was used: A/G  R, A/C  M, A/T  W, G/O  S, G/T  K, C/T  Y, A/G/O  V, A/G/T  D, A/C/T  H, G/C/T  B,
A/G/C/T  N. Not shown here are sequences of additional standard cag PAI primers, designed from known H. pylori sequences (5, 47) and used to test for the possible
presence of any cag genes (but for which no amplification was obtained), as detailed in the text. Sequences are available from authors on request.
b Series of primer pairs used for vacA H. acinonychis sequencing.
c Primer specific for H. acinonychis.
d For PCR amplification of vacA mid-region; each primer was used for sequencing.
e For vacA m2.
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following: (i) our sequence analyses of three other cag PAI
genes (hp520, picA, and picB) in a global H. pylori strain col-
lection and the finding that they were no more diverse than
housekeeping (metabolic) genes (G. Dailide, M. Ogura, and
D. E. Berg, unpublished data), which were readily amplified
from H. acinonychis DNA (see below); and (ii) a sense that
most genes whose proteins act internally in bacterial cells,
unlike cagA, should not have been subject to diversifying se-
lection. Second, as independent evidence that H. acinonychis
does not contain the cag PAI, PCR products of sizes expected
for cag PAI empty sites were obtained using primers specific
for flanking genes (hp519 and glr; 0.53 and 0.85 kb, depending
on primers used). Sequences from these products (GenBank
accession numbers AY269155 and AY269157) were 91%
matched to one another and 93% matched (group I) and 86%
matched (group II) to corresponding empty sites of H. pylori
clinical isolates that also lack the cag PAI (GenBank accession
nos. AF084492 and AF084493, respectively). We conclude that
these H. acinonychis strains lack a cag PAI.
vacA status. PCR products were obtained from both groups
of H. acinonychis isolates with primers that are specific for
relatively conserved sites in the middle region of the vacA gene
(vam-F and vam-R; Table 1). Products were also obtained with
primers specific for the 5 end (signal sequence region; va1-F
and va1-R), although these products were 240 and 121 bp long
(group I and II isolates, respectively), not 259 or 286 bp, which
are obtained with H. pylori vacA s1 or s2 alleles, respectively
(Table 1).
The sequence of a 4,006-bp DNA fragment containing the
vacA gene from a group I strain (89-2579, from a cheetah) was
determined (GenBank accession no. AY269171). It was 84%
identical to the most closely related of currently available (as of
July 2003) H. pylori vacA sequences (GenBank accession no.
AF050327; strain CHN5114a). It differed from this H. pylori
sequence by nine insertions and eight deletions ranging from 3
to 59 bp and 43 translational stops (due variously to out-of-
frame insertions and deletions and base substitutions [non-
sense codons]). The first 2.2 kb of vacA from a group II strain
(Sheena) was also sequenced (GenBank accession no.
AY269176). It differed from the corresponding part of the
group I vacA sequence by 5.8% base substitutions and 11
insertions and deletions and from the corresponding part of
the vacA sequence of H. pylori strain CHN5114a by 13 inser-
tions and deletions and 22% base substitutions. The many
disruptions of vacA open reading frames indicated that these
vacA genes would not encode an active vacuolating cytotoxin
or a full-length VacA protein.
Additional sequencing of vacA-containing segments from
the two group I strains from lions in Europe (724 bp of the
vacAs region from Sheeba; 996 bp of vacAs and 664 bp of the
vacAm regions from Mac) identified only a 1-bp difference
from the sequence of the U.S. cheetah strain (in the vacAs
segment). This near-identity suggests that vacA-null alleles ex-
isted while these H. acinonychis strains infected big cats and
were not artifacts of laboratory culture.
FIG. 1. RAPD fingerprinting identified two groups of H. aci-
nonychis strains. Profiles shown were obtained with RAPD primers
1247 (A), 1254 (B), 1281 (C), and 1283 (D). With each DNA sample,
RAPD tests were run with 5 ng (left lane) and with 20 ng (right lane)
of template DNA to identify subtle differences that are reproducible
and thus informative. Arrowheads identify bands that distinguish dif-
ferent strains of the same group. Lane pairs 1, 2, and 3 contain profiles
of group I isolates (cheetah strain 89-2579, Mac, and Sheebah, respec-
tively); lane pairs 4 and 5 contain profiles of group II isolates (Sheena
and India, respectively). The profiles of cheetah strain 89-2579 shown
here are representative of those obtained from other cheetah isolates,
except for strain 90-548, which reproducibly yielded one extra band
(1.1 kb) with primer 1254. m, marker DNA.
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Relatedness assessed with functional genes. Further se-
quence analyses were carried out using nine genes that are
probably needed in vivo and thus likely to be intact, not inac-
tivated by mutation: six housekeeping genes (glr, just to the
right of the cag PAI; cysS, just upstream of vacA; and glmM,
recA, atpA, and ppa), the flaA and flaB flagellin genes, and
hp519, a putative regulatory gene just to the left of the cag PAI.
PCR products of sizes expected based on H. pylori sequences
were obtained for each gene from both groups of H. aci-
nonychis strains. Because the primers used had been designed
from H. pylori sequences, all amplification was carried out with
low-stringency (52°C) annealing. The sequences of PCR prod-
ucts obtained from group I and II isolates differed from one
another by about 1.8%, on average (Table 2). However, iden-
tical sequences were found in 645 bp of flaA and in all but 142
of the 1,080 bp of atpA (Table 2). These matches were note-
worthy because identical sequences are only rarely found in
independent H. pylori isolates. In addition, sequences identical
to those of the U.S. cheetah strain (group I) were found in all
genes sequenced from the European group I strains (glmM,
recA, hp519, glr, cysS, and atpA from Mac; glmM and atpA from
Sheeba). Similarly, the two group II strains were identical at all
but 1 bp in the five genes sequenced from both of them (glmM,
recA, hp519, glr, and cysS). Thus, these sequence and RAPD
profile data (Fig. 1) each showed that these 10 H. acinonychis
isolates belong to just two major lineages.
The H. acinonychis genes, other than vacA, that were ana-
lyzed were about 8% divergent from homologs in H. pylori
reference strains such as 26695 (47) and J99 (5). The close, but
distinct, species relationship between H. acinonychis and H.
pylori is further illustrated by comparison of flaA and flaB gene
sequences (Fig. 2). We note that two of the genes analyzed
here, ppa and atpA, had also been studied in an unusual out-
group of H. pylori strains from South Africa (17). The ppa and
atpA sequences from H. acinonychis were more closely related
to those of the South African H. pylori outgroup (4.7% DNA
divergence, on average) than either the H. acinonychis or out-
group sequences were to those of most other known H. pylori
strains, including reference strains 26695 and J99 (divergences
of 6.6 and 7.6% between sequences from reference H. pylori
strains versus outgroup H. pylori strains and versus H. aci-
nonychis, respectively).
FIG. 2. The neighbor-joining tree of Helicobacter flagellin genes inferred from DNA sequences confirmed the separate species groupings of H.
acinonychis strains. The H. acinonychis sequences were determined here. All other sequences are from the GenBank public database. Left, FlaA;
right, FlaB.
TABLE 2. DNA sequence relationships of group Ia and group IIa H. acinonychis strains to each other and to a reference H. pylori straina
Comparison
% Identity with gene (sequence length [bp])
Avg
glmM (648) flaB (615) recA (642) hp519 (726) glr (768) flaA (645) cysS (659) atpA (1,080) ppa (427)
Cheetah (I) vs 26695 91.8 89.8 93.6 91.9 91.7 91.3 93.4 93.7 93.7 92.4
Sheena (II) vs 26695 91.9 88.8 93.6 91.2 91.1 91.3 93.6 93.5 92.7
Cheetahb (I) vs Sheena (II) 97.9 97.7 98.7 95.6 97.3 100 97.5 99.3c 97.2 98.2
a Group I and group II refer to sets of H. acinonychis strains with the different RAPD profiles illustrated in Fig. 1 and described in the text; 26695 is a reference strain
of H. pylori whose genome has been fully sequenced.
b Cheetah refers to strain 89-2579 from a cheetah. However, where tested, identical corresponding sequences were found in isolates from other cheetahs as well.
c Divergence in atpA consists of 7 nt substitutions in 142 bp of the 1,080 bp sequenced.
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Susceptibility to MTZ. Resistance to the important anti-
Helicobacter drug MTZ is common among strains of both H.
acinonychis and H. pylori (8, 13, 26), probably in part because
it is also much used against anaerobic and parasitic infections.
The susceptibility or resistance of each H. acinonychis isolate
to MTZ was characterized, in part, to help choose Mtzs strains
for mouse infection studies (below). Two of the six Ohio zoo
isolates and three European circus isolates were MTZ sensitive
(MIC  1.5 g of MTZ/ml [or in one case, 3 g of MTZ/ml]),
and the other five isolates were moderately or highly resistant
(MIC range from 8 to 128 g of MTZ/ml) (Table 3). Two types
of Mtzs H. pylori are known and can be distinguished by the
ease of mutation to resistance: type I requires inactivation of
just the rdxA nitroreductase gene (because the related frxA
gene is quiescent), and type II requires inactivation of both
rdxA and frxA (26, 34). The three mouse-colonizing strains of
H. pylori characterized to date (SS1, X47, and 88-3887) are
each type II (26, 34). Camr transformants of Mtzs H. aci-
nonychis isolates were generated using an rdxA::cat (null) allele
from H. pylori. Each Camr transformant was Mtzr, with MTZ
MICs of 32 and 16 g per ml in group I and II strains, respec-
tively (Table 3), suggesting that the frxA nitroreductase gene is
either quiescent or absent from these strains. The small differ-
ences in MICs were reproducible and suggested quantitative
differences in parameters such as basal levels of other nitrore-
ductases, of MTZ uptake, or of repair of MTZ-induced DNA
damage (see references 26 and 34).
Adaptation to mice. An earlier effort to achieve H. aci-
nonychis infection of BALB/c mice was not successful (13).
Here, we also attempted to isolate mouse-colonizing H. aci-
nonychis strains, but this time we used IL-12-deficient
C57BL/6J mice, which seem more permissive than congenic
wild-type C57BL/6J or BALB/c mice for H. pylori (19, 24, 36),
and pools of isolates, rather than just a single strain, to avoid
possible problems of strain attenuation in culture. H. aci-
nonychis organisms were recovered 2 weeks after inoculation
from each of four mice that had received Mtzs group I strains
(89-2579 and 90-624; Sheeba and Mac) (20 to 500 CFU per
stomach) and also from two of four mice that had received
group II strains (India and Sheena) (about 2,000 CFU per
stomach). These pools of recovered H. acinonychis organisms
were used in a second inoculation of IL-12-deficient mice;
1,000 to 3,000 CFU were recovered 2 weeks later from each of
10 mice (5 inoculated with each H. acinonychis group). No
further increase in bacterial yield was seen after a third cycle of
infection of IL-12-deficient mice. RAPD fingerprinting, as
shown in Fig. 1, suggested that these mouse-adapted strains
were derived from a cheetah isolate (group I) and from Sheena
(group II). These strains, now adapted to IL-12-deficient
mice, were used to inoculate wild-type C57BL/6J and BALB/cJ
mice: 1,000 to 3,000 CFU were obtained per C57BL/6J mouse
stomach at 2 weeks and also at 12 weeks after inoculation (five
mice per time point per strain); 1,000 to 3,000 CFU and 500 to
1,000 CFU were obtained per BALB/cJ mouse stomach inoc-
ulated with group I and group II strains (five mice in each
group). Thus, H. acinonychis strains selected initially for colo-
nization of C57BL/6J IL-12-deficient mice were also well
suited for infection of two other wild-type lines (C57BL/6J and
BALB/cJ).
H. acinonychis-H. pylori mixed infection. The similar genetic
distances of H. acinonychis and the African H. pylori outgroup
to other H. pylori strains, the ease of DNA transformation
between the two species in culture, and interest in evolutionary
consequences of interspecies gene transfer led us to test for
mixed infection in vivo. In the first test, mice were inoculated
with H. acinonychis and also SS1 or X47, H. pylori strains that
colonize mice at high density but at different preferred gastric
sites (SS1 in the antrum, X47 in the corpus) (2). Mice were
sacrificed 2 weeks later, gastric contents were cultured, and
single colonies were tested by PCR or by susceptibility when
SS1 was marked genetically (Tetr) to distinguish the two spe-
cies. Based on these tests, only 6 of 336 colonies from the
mixed inoculation with SS1 were of the H. acinonychis type;
similarly, just 1 of 96 colonies from the mixed inoculation with
X47 was of the H. acinonychis type (Table 4). A sequential
inoculation protocol was used next, to assess if the low yield of
H. acinonychis might be due primarily to inefficient initiation of
infection. A vacA-null (Camr) derivative of H. pylori strain SS1
was used because vacA is needed by this strain to initiate
infection efficiently but not to maintain it after the first few
critical days (42). Mice were inoculated with group II H. aci-
nonychis first and then with H. pylori 1 week later; the mice
were sacrificed and Helicobacter was cultured from them 2
weeks after superinfection. All but 6 of 230 single colonies
tested (at least 20 per mouse) was resistant to chlorampheni-
col, indicating that most were of the SS1 vacA-null type (Table
4). Equivalent sequential inoculation tests were carried out
using a Clar derivative of strain X47; all but 14 of 284 colonies
tested was similarly of the Clar X47 type (Table 4). These
results emphasized that H. pylori strains SS1 and X47 can each
outcompete H. acinonychis, even if inoculated a week after the
H. acinonychis infection has started.
Given H. pylori’s genetic diversity, it seemed that other
mouse-adapted strains might be less vigorous or differ in tissue
tropism from strain SS1 or X47 and, therefore, be able to
establish a more balanced mixed infection with H. acinonychis.
This was tested first by inoculating mice with genetically
marked derivatives of H. acinonychis (Tetr group I, Clar group
II) and of H. pylori strain 88-3887 (Camr; rdxA::cat) and scoring
the types of helicobacters recovered 2 weeks later by drug
TABLE 3. MTZ susceptibility profiles of H. acinonychis strains
Strain RAPDa group
MIC (g of MTZ/ml)b for:
WT rdxA::cat (null)
89-2579 I 1.5 32
90-624 I 1.5 32
90-736 I 16 NT
90-548 I 32 NT
90-119 I 128 NT
90-788 I 128 NT
Mac IA 1.5 32
Sheeba IA 1.5 NT
Sheena II 3 16
India II 8 16
a RAPD groups are defined in the legend for Fig. 1. The subtle differences in
RAPD profiles between group I strains from cheetahs in a U.S. zoo and the
strains from lions in a European circus (here designated group IA) are also
illustrated in Fig. 1.
b In the present usage, MIC indicates the lowest concentration of MTZ used
that resulted in at least a 100-fold reduction in efficiency of colony formation.
WT, wild type; NT, not tested.
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resistance patterns. Figure 3 (left panel) shows that H. aci-
nonychis was recovered from 14 of 20 mice coinoculated with
these two species. Similar mixed infections were obtained after
coinoculation with H. acinonychis group I and either of two
other mouse-adapted H. pylori strains (AM1 and AL10103)
(data not shown), indicating that the ability to coexist with H.
acinonychis is not unique to strain 88-3887.
A final set of coinfection studies was carried out by first
inoculating mice with Tetr or Clar H. acinonychis, superinfect-
ing them with Camr 88-3887 1 week later, and scoring the types
of helicobacters recovered at 1, 3, and 8 weeks after superin-
fection. Much as with simultaneous inoculations, persistent
mixed infections were found in just over half of the mice
examined (Fig. 3, right): 5 of 9 mice scored at 1 week, 5 of 10
scored at 3 weeks, and 6 of 10 scored at 8 weeks after super-
infection.
Variants accumulated during 8 weeks of mixed infection.
One Tets derivative of H. acinonychis group I and one Cams
FIG. 3. Mixed infections resulting from simultaneous and sequential inoculations with genetically marked H. acinonychis and H. pylori. The
mutations conferring resistance to Tet and to Cla are in 16S and 23S rDNAs, respectively (9, 49). Cam resistance is conferred by a chloramphenicol
acetyltransferase gene (cat) inserted in the rdxA nitroreductase gene of H. pylori strain 88-3887 (25, 34). Frequencies of each strain type were
estimated by testing 20 single colonies per mouse for antibiotic susceptibility and also by colony counts on selective agar. Weeks refers to time
between superinfection and mouse sacrifice and culturing of Helicobacters that they harbored.
TABLE 4. H. pylori strains SS1 and X47 outcompete H. acinonychis
Input No. of colonies recovered
No. of mice Single-colony testmethodH. acinonychis H. pylori H. acinonychis H. pylori
Tests of single colonies
I SS1 WTa 0b 48 4 PCR
I SS1 Tetr 2 118 4 Phenotype
II SS1 WT 1b 47 4 PCR
II SS1 Tetr 3 117 4 Phenotype
I X47 WT 0b 48 4 PCR
II X47 WT 1b 47 5 PCR
Sequential infectionc
II SS1 vacA::cat 6 230 9 Phenotype
II X47 Clar 14 284 9 Phenotype
a WT, wild type.
b PCR tests using pools of 1,000 colonies and primers vac5-1-F and vac5-1-R indicated that H. acinonychis was also present in each mixed infection.
c Mice received H. acinonychis first and then H. pylori superinfection 1 week later.
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derivative of H. pylori were found among 337 Helicobacter
colonies recovered 8 weeks after superinfection and screened
for drug susceptibility (66 group I and 72 group II H. aci-
nonychis; 199 H. pylori) (experiment in Fig. 3, right) (species of
two susceptible isolates were identified by RAPD test). Anal-
ysis of the 16S rDNA sequence of the Tets isolate indicated
that it arose by interstrain recombination involving the 16S
rDNA genes: a replacement of a short patch in H. acinonychis
(less than 137 bp) containing TTC (resistant allele) by AGA
(sensitive allele) at positions 965 to 967. In contrast, PCR tests
of the Cams H. pylori variant with rdxA- and cat-specific prim-
ers revealed only a normal-length rdxA::cat insertion allele, not
an intact rdxA allele. In addition, Camr revertants of this Cams
rdxA::cat strain were obtained at frequencies of about 10	6. No
equivalent Camr mutants were detected among 108 cells of an
isogenic control strain that lacks cat gene sequences. We there-
fore infer that this variant arose by mutation, not by replace-
ment of the rdxA::cat allele with the intact rdxA gene of H.
acinonychis.
Two other variants, both H. pylori, were found by RAPD
fingerprinting of 39 isolates (23 H. pylori; 6 group I and 10
group II H. acinonychis; Fig. 3, right); the primer 1247 profile
of one variant lacked a characteristic 0.5-kb RAPD band,
and that of the other contained an extra 0.9-kb band that
comigrated with a characteristic H. acinonychis band (Fig. 4).
No other difference from the input H. pylori strain was found in
RAPD tests with any of four RAPD primers.
DISCUSSION
Two groups of H. acinonychis strains were identified: one
group consisting of isolates from six cheetahs from a U.S. zoo
and two isolates from lions from a European circus, and the
other group consisting of isolates from two other felines (a
tiger and a lion-tiger hybrid) from the same circus. The two
groups differed from one another by about 2% in gene se-
quence, on average, but were identical in one gene (flaA) and
in most of another (atpA), a pattern suggesting recombination
between lineages. Such exchange might have occurred during
mixed infection in captivity, perhaps following direct contact
between infected animals or transmission by human handlers.
More remarkable, from an H. pylori perspective, was the near-
identity of H. acinonychis isolates from the United States and
Europe, since any given H. pylori isolate is usually easily dis-
tinguished from other independent isolates by the DNA tests
used here (4, 17). Having so few H. acinonychis genotypes
implies disproportionate contributions from very few index
cases (a genetic bottleneck) and/or a far more epidemic mode
of transmission of H. acinonychis in captive big cats than of H.
pylori in humans.
Derivatives that could chronically infect mice were readily
obtained from each H. acinonychis group using C57BL/6J IL-
12 knockout mice as initial hosts and C57BL/6J and BALB/cJ
wild-type mice later. H. acinonychis was so-named because it
was first isolated from cheetahs (12, 13), and it is associated
with severe gastritis, a frequent cause of their death in captivity
(8, 12, 13, 35). H. acinonychis’ ability to infect other felids
(illustrated by the present lion and tiger isolates) and mice
raises questions about its host range in nature. Are cheetahs or
other big cats necessarily its only, or even most common, nat-
ural host? Or, might H. acinonychis also often infect other
carnivores and/or even the herbivores on which they prey?
Any flexibility in Helicobacter host range bears on discus-
sions of how and when H. pylori became a human pathogen (7).
The popular ancient-origins theory envisions near-universal H.
pylori infection in hominids for perhaps millions of years (6,
17). Our alternative theory envisions H. pylori infection of
humans becoming widespread more recently, perhaps in early
agricultural societies (29), facilitated by close animal-human
contact and increased chances for person-to-person spread
(10). The ease of adapting H. pylori to mice and other animals
(11, 18, 19, 21, 31, 39) illustrates again that potential host
species barriers are easily surmounted. Also noteworthy is an
unusual outgroup of H. pylori strains from Africa, some 7%
divergent from the more-abundant groups of H. pylori strains
in housekeeping gene sequences (17). Although initially inter-
preted as representing an ancient H. pylori lineage sequestered
until recently in a very isolated group of humans (17), this H.
pylori outgroup seemed more closely related to H. acinonychis
than either it or H. acinonychis were to predominant H. pylori
groups. Thus, the data also fit with a model in which the
ancestors of this H. pylori outgroup jumped from animals to
people recently during human evolution. By extrapolation, the
more-abundant groups of human-adapted H. pylori strains
might also have been acquired quite recently by humans.
H. pylori strains SS1 and X47 were far more fit than H.
acinonychis in mice: even after H. acinonychis had begun to
establish itself, it was displaced soon after superinfection by
these stronger H. pylori strains. In accord with this finding are
preliminary observations that these two strains each also out-
compete strain 88-3887 (M. Zhang, D. Dailidiene, and D. E.
Berg, unpublished data). In further tests using strains that were
genetically marked (for efficiency in scoring many colonies),
derivatives of H. acinonychis (Tetr or Clar) were able to estab-
lish mixed infections with derivatives of H. pylori 88-3887
(rdxA::cat; Camr) and also with two other mouse-adapted H.
FIG. 4. RAPD fingerprinting (primer 1247) identified two variant
H. pylori strains isolated after 2 months of mixed infection with H.
acinonychis in C57BL/6J IL-12 knockout mice. With each DNA sam-
ple, RAPD tests were run with 5 ng (left lane) and with 20 ng (right
lane) of template DNA, as for Fig. 1. White arrowheads identify bands
that distinguish variants. m, marker DNA.
VOL. 186, 2004 GENETICS OF H. ACINONYCHIS 363
 o
n
 April 22, 2014 by W
ashington University in St. Louis
http://jb.asm.org/
D
ow
nloaded from
 
pylori strains (AM1 and AL10103). In a sequential-infection
experiment, half of the mice inoculated first with H. aci-
nonychis and then H. pylori 88-3887 a week later harbored
quite similar levels of the two species 8 weeks after superin-
fection. We suggest that such experimental mixed infections
may provide good models for understanding the human con-
dition, especially in many developing countries, where risks of
infection are high for children and also for adults (23, 44).
Two cases of genetic change were detected among 337 sin-
gle-colony isolates that were tested for drug resistance mark-
ers: a loss of tetracycline resistance from H. acinonychis by
interstrain recombination and a loss of chloramphenicol resis-
tance from H. pylori, but by mutation not recombination. This
one case of mutation (among only 199 H. pylori isolates) was
unexpected, but it is in accord with other indications that
mutation can be frequent in this species (50). Two changes in
the RAPD profile were also found in the screening of 39
isolates: one gain of an H. acinonychis-like RAPD band and
one loss of a characteristic H. pylori band. Precedent suggests
that these two variants may have arisen by interstrain recom-
bination (28), although the possibility of a mutational origin
also merits consideration.
People, like other mammalian hosts, are diverse in traits that
can be important to individual H. pylori strains—for example,
in distribution or abundance of carbohydrate structures that H.
pylori uses for adherence, in gastric acidity, in the repertoire of
host defenses, and in the history of other infections that in turn
affect host responses to H. pylori (11, 20, 25, 33). H. pylori, in
turn, is extraordinarily diverse genetically, in part probably
because of legacies of diversifying selection in a succession of
hosts and because of transmission patterns that minimize
chances of population-wide selection for any one or a few
most-fit genotypes. Given H. pylori’s great genetic diversity, an
important challenge will be to identify those polymorphic de-
terminants in helicobacters that contribute to colonization and
disease—a bacterial counterpart of the quantitative trait loci
that determine many aspects of the phenotypes of humans and
other higher organisms (32). We suggest that H. acinonychis
may have just the right mix of moderate genetic distance from
and similarity in physiology and gastric tropism to H. pylori for
such studies. Mouse-adapted H. acinonychis should be valuable
as a resource for analysis of the interplay between Helicobacter
and its host that shapes the specificity and vigor of infection,
the risks of various types of disease, and the evolutionary
trajectories that may result.
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